TL;DR: A 2026 mouse study in The Journal of Neuroscience found that the HIV-1 protein gp120 amplified pain signaling through α2δ-1-bound NMDA receptors in spinal excitatory neurons, and blocking that receptor coupling reversed pain-like hypersensitivity. Key Findings More than 60% chronic pain: The source context notes that sensory neuropathy and chronic pain affect more than …
TL;DR: A 2026 study in Open Life Sciences reported that ELAVL1, an RNA-binding protein, protected stressed retinal cells by maintaining WDR36 protein, reducing p53 activation, and limiting calcium overload in cell and acute mouse pressure-injury models. Key Findings OGD/R cell stress: Oxygen-glucose deprivation/reoxygenation reduced ELAVL1 and WDR36 protein in R28 retinal precursor cells. mRNA-protein mismatch: …
TL;DR: A 2026 mouse study in Nature Communications found that early-life high-fat/high-sugar diet exposure left sex-specific adult feeding and hypothalamic changes, and microbiota-targeted interventions partly restored those effects. Key Findings Early-life HFHS exposure: Mice exposed to a high-fat/high-sugar diet only in early life showed persistent adult feeding changes despite normalized body weight. Sex-specific vulnerability: Females …
TL;DR: A reviewed preprint in eLife found that adult vestibular hair-cell kinocilia carry both primary-cilia and motile-cilia features, including motile-cilia gene signatures and spontaneous motion in bullfrog and mouse balance organs. Key Findings 1,522 mouse hair cells: The single-cell RNA-seq dataset included cochlear inner and outer hair cells plus vestibular type I and type II …
TL;DR: A 2026 preprint in medRxiv reported that a urine beta-amyloid protein test kit separated mild cognitive impairment or Alzheimer’s disease from healthy controls in a multicenter Chinese sample, while a 51,187-person community screen showed age-related positive rates. Key Findings 898-person validation sample: The multicenter case-control arm included 266 healthy controls, 167 people with mild …
TL;DR: A 2026 computational study in PLOS One used GEO Alzheimer’s datasets, 130 machine-learning models, and molecular simulations to identify eight candidate genes that may sit in a trichostatin A-related Alzheimer’s disease network. Key Findings 949 predicted TSA targets: The analysis started with predicted human protein targets for trichostatin A, a histone deacetylase inhibitor. Five …
TL;DR: A 2026 study in Biological Psychiatry: Global Open Science linked serious physical injury to recurrent major depression and found that injury-related DNA methylation patterns differed by depression status, with oxytocin, GABA, and synaptic-plasticity pathways standing out. Key Findings Large cohort anchor: researchers analyzed 4,308 Generation Scotland participants with or without a reported fracture from …
TL;DR: A 2026 study in Brain, Behavior, & Immunity – Health reported that Theiler’s murine encephalomyelitis virus (TMEV), a mouse neurotropic virus, infected substantia nigra dopamine neurons and produced Parkinson’s-like motor deficits in mice. Key Findings 13 TMEV mice vs 14 controls: The main behavioral experiment compared unilateral TMEV injection into the substantia nigra with …
TL;DR: A 2026 preprint in medRxiv reported that one session of left central thalamus focused ultrasound increased behavioral responsiveness scores in 16 adults with chronic disorders of consciousness, with no severe adverse events reported. Key Findings 16 chronic DOC patients: Adults had chronic disorders of consciousness after severe brain injury, with an average time since …
TL;DR: A 2026 review in CNS Drugs argues that seletracetam, an unapproved SV2A-targeting antiseizure drug, may deserve renewed development as a low-volume intranasal non-benzodiazepine rescue treatment for acute repetitive seizures. Key Findings SV2A racetam: Seletracetam is a second-generation racetam related to levetiracetam and brivaracetam. Phase IIa history: Oral seletracetam reached early clinical trials but was …
